Memo from E. H. W. Luxton (PD) to C. Wilson, re Profiltrate Factor VII. Refers to BPLs estimates that they meet 70% of NHS requirements for Factor VIII and that Alpha estimate to have 80% of the rest of the UK market. States BPL and other suppliers have sufficient short-term reserve stock to cope with the suspension of Profilate. Also asks for a Drug Alert recall/Hazard Notice to be issues for Profilate to be taken out of use.